Because of the potential environmental impact of pesticides and the large population potentially exposed, the effects of chronic exposure to pesticides need to be determined. Mutagenicity studies have been used to identify specific agents as potential carcinogens or other human health hazards. However, short-term tests are only theoretically correlated to carcinogenesis because their end points can measure only the genotoxic potential ofchemicals, i.e, their activities as initiating agents in multistep carcinogenesis. The objective of our research presented here is to provide a comprehensive examination of the mechanism of toxicity of a series of pesticides. These are substances for which toxicity, at both the genetic and metabolic level, has not been adequately described. Preliminary results on a broad series of compounds belonging to different biological classes (herbicide, insecticide, fungicide) seem to indicate that pesticides are toxic but are poor initiating agents, as shown by negative or weak positive results on different genetic end points (gene mutations, DNA effects, and chromosome aberrations in vitro and in vivo). Immunochemical and biochemical studies, however, seem to indicate the cocarcinogenic and promoting potential of these chemicals. As an example, the genotoxic and biochemical effects induced by Fenarimol (a fungicide) are discussed. The results reported stress the importance of identifying chemicals that act at different levels of the multistep carcinogenesis process to ascertain the risk associated with exposure.
Introduction
The broad use of pesticides represents a potential risk to humans and to the environment. A principal goal in pesticide research and development is identifying the specificity of action of a pesticide toward the organisms it is supposed to kill. Only the target plant, animal, insect or fungus should be affected by the application ofthe product. However, because pesticides are designed and selected for their biological activity, toxicity to nontarget species usually remains a signiflcant potential problem (1) .
i Unintended exposure to pesticides can occur during manufacture, formulation, application, or from environmental residues after application. Because each type of exposure has its own characteristics of magnitude and duration and may lead to different toxicity, it is important to consider efficacy and safety simultaneously. One of the factors underlying the increased concern about the health hazards associated with the use of pesticides is a growing awareness of the hazards associated with long-term exposure to some of these chemicals that are persistent in soil (organochlorine and carbamate insecticides and certain herbicides). The insidious nature of effects such as mutagenicity and carcinogenicity has drawn the attention of scientists and government agencies. More Zeiger (4, 5) and Tennant (6) ].
Short-term tests mimic only a part of the phenomena that would occur in vivo (7) . Cancer is now known to be a multifactorial, multistage, and multimechanistic disease in which many factors are relevant (8, 9) . When chemicals are shown to be mutagenic and induce cancer in a dosedependent manner in animals, they are generally regarded as important carcinogens because they initiate the disease, as stipulated by the somatic mutation theory. However, recent research has shown that factors modifying the progression of the disease (promoters and inhibitors) may be considerably important as risk determinants (10, 11) .
Our approach to studying the potential risk from pesticides consists of the development of a database of toxicological information (general toxicology, mutagenesis, and carcinogenesis) on pesticides. Risk assessment from experimental studies is based on a comprehensive examination on the mechanism of toxicity at the genetic and metabolic (biochemical) levels. With regard to genotoxicity studies, particular attention is given to cytogenetic assays because chromosome aberration end points can be used as an early warning signal for development of cancer (12) . Experimental results are further evaluated with a semi qualitative approach using categories of concern (2,3). Preliminary results on a broad series of compounds, belonging to different biological classes (herbicides, insecticides, fungicides) seem to indicate that most pesticides are toxic but are poor initiating agents, as shown by negative or weak positive results at different genetic end points (13, 14) . Biochemical and immunochemical studies show that pesticides induce mixed-function oxidase enzymnes (P-450IIB1) in different organs of rodents indicating a cotoxic, cocarcinogenic and promoting potential of these chemicals (Paolini and Cantelli-Forti, unpublished results).
The promoting properties of cytochrome P-450IIB1 subfamily of isozymes inducers (e.g., barbiturates, haliphatic halogenated hydrocarbons) are acknowledged. However, it should be noted that other inducers such as alcohols (P-450IIE1) and dioxins (P-450IA2) are promoters also (15, 16 peripheral lymphocytes (21) and an assessment of the micronuclei frequency in mouse bone marrow using the acridine orange staining method (22, 23 albino CD1 strain) with three different doses of Fenarimol, from 75 to 300 mg/kg body weight, resulted in significant increases of micronucleated erythrocytes (up to 5-fold over the control; p < 0.01), as detected in bone marrow smears (Fig. 2) . The increases are dose related until a depression of erythropoiesis appeared at the higher dose, corresponding to the 50% of the LD50, previously evaluated. The disagreement of results obtained in the two cytogenetic assays suggests that Fenarimol may act as an aneugen and not a clastogen. This hypothesis, supported by the reported effect of Fenarimol on distribution of chromosomes leading to mitotic nondisjunction in Aspergillus nidulans (20) , needs to be validated by further experiments.
To ascertain the possible cotoxic, cocarcinogenic, and promoting properties of Fenarimol, the ability to modulate specific P-450-dependent activities in the mouse was studied. For this purpose, the fungicide was administered IP at 150 or 300 mg/kg body weight in male mice (Swiss albino CD1 strain), and the purified microsomal fraction was then prepared from liver, kidney, and lung (25) . NADPHcytochrome (P-450)c-reductase activity and selected substrates (as probes) of specific P-450 isoenzymes, such as pentoxyresorufin (P-450IIB1), ethoxyresorufin (IA1), aminopyrine (IIIA), and ethoxycoumarin toward unspecific P-450 isoforms were used (25) .
The dealkylation of pentoxyresorufin was significantly increased up to 6.9-fold at 150 mg/kg dose in liver (Fig. 3) .
On the contrary, no significant changes in the P-450IA1-dependent oxidases was observed (Fig. 3) . A similar pattern of enzymatic activity was recorded in kidney and lung microsomes. An enhancement of IIBl-like activity up to 2.2-and 3.8-fold in kidney (Fig. 4) and 2.5-and 2.6-fold in lung microsomes (Fig. 5) The importance of this phenomenon has come from the consideration that, independent of the possible mutagenic (and/or teratogenic) property, a chemical inducing P-450 function can have serious toxicological and/or genetic consequencies. In addition to the increase of oxidative, reductive, and peroxidative metabolism of pretoxics and premutagens/precarcinogens (cotoxicity and cocarcinogenicity), and the fact that an inducer can act as promoter in the multistep process of carcinogenesis (at least for classes IIB1, IA2, and IIEl P-450s), P-450 induction per se can have a role in the development of malignancy (25, 26) Indeed, the production of several oxygen-centered radicals associated with the enhancement of phase-I reactions [reviewed in Bost (27) ] can determine "oxidative stress" contributing to the carcinogenic potential, particularly of nongenotoxic carcinogens such as many pesticides (26) .
The experimental approach presented, by evaluating the effects of pesticides at different levels of the multistep carcinogenic process (e.g., initiation and promotion) is fundamental to achieving a more complete and accurate evaluation of the genotoxic/carcinogenic profile of a pesticide. The generation of data at significant biological end points contributes to the design of regulatory instruments through which risk to humans can be minimized. Knowledge of the genetic and biochemical damage at various organ sites can be used in assessing the probable risk of the chemical. An example is represented by the semiqualitative approach using categories of concern for both mutagenicity and carcinogenicity (2, 3) .
